BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31609150)

  • 1. Increased circulating CD3
    Batorov EV; Pronkina NV; Tikhonova MA; Kryuchkova IV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Aristova TA; Batorova DS; Shishkova IV; Gilevich AV; Shevela EY; Ostanin AA; Chernykh ER
    Leuk Lymphoma; 2019 Oct; 60(10):2488-2497. PubMed ID: 31609150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating CD4
    Batorov EV; Tikhonova MA; Pronkina NV; Kryuchkova IV; Sergeevicheva VV; Sizikova SA; Ushakova GY; Aristova TA; Batorova DS; Menyaeva EV; Gilevich AV; Shevela EY; Ostanin AA; Chernykh ER
    Oncotarget; 2018 Jun; 9(43):27305-27317. PubMed ID: 29930767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.
    Merryman RW; Redd R; Jeter E; Wong JL; McHugh K; Reynolds C; Nazzaro M; Varden A; Brown JR; Crombie JL; Davids MS; Fisher DC; Jacobsen E; Jacobson CA; Kim AI; LaCasce AS; Ng SY; Odejide OO; Parry EM; Dahi PB; Nieto Y; Joyce RM; Chen YB; Herrera AF; Armand P; Ritz J
    Transplant Cell Ther; 2022 Jan; 28(1):32.e1-32.e10. PubMed ID: 34670169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry CD4(+)CD26(-)CD38(+) lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes.
    Di Gaetano R; Gasparetto V; Padoan A; Callegari B; Candiotto L; Sanzari MC; Scapinello A; Tagariello G
    Ann Hematol; 2014 Aug; 93(8):1319-26. PubMed ID: 24627194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation.
    Schlenke P; Sheikhzadeh S; Weber K; Wagner T; Kirchner H
    Bone Marrow Transplant; 2001 Aug; 28(3):251-7. PubMed ID: 11535992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34
    Salzmann-Manrique E; Bremm M; Huenecke S; Stech M; Orth A; Eyrich M; Schulz A; Esser R; Klingebiel T; Bader P; Herrmann E; Koehl U
    Front Immunol; 2018; 9():1841. PubMed ID: 30154788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma.
    Akhtar S; Elhassan TAM; Edesa W; Rauf MS; Zahir MN; Maghfoor I
    Ann Hematol; 2016 Jan; 95(1):49-54. PubMed ID: 26467917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Milgrom SA; Jauhari S; Plastaras JP; Nieto Y; Dabaja BS; Pinnix CC; Smith GL; Allen PK; Lukens JN; Maity A; Oki Y; Fanale MA; Nasta SD
    Cancer; 2017 Apr; 123(8):1363-1371. PubMed ID: 27984652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants.
    Rutella S; Rumi C; Laurenti L; Pierelli L; Sora' F; Sica S; Leone G
    Br J Haematol; 2000 Jan; 108(1):105-15. PubMed ID: 10651733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
    Lee L; Alrasheed N; Khandelwal G; Fitzsimons E; Richards H; Wilson W; Chavda SJ; Henry J; Conde L; De Massy MR; Chin M; Galas-Filipowicz D; Herrero J; Chain B; Quezada SA; Yong K
    Front Immunol; 2021; 12():618610. PubMed ID: 33717112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune recovery of lymphocyte subsets 6 years after autologous peripheral blood stem cell transplantation (PBSCT) for lymphoproliferative diseases. A comparison between NHL, HD and MM in group of 149 patients.
    Laurenti L; Piccioni P; Piccirillo N; Sora' F; Chiusolo P; Garzia M; Reddiconto G; De Matteis S; Tarnani M; Leone G; Sica S
    Leuk Lymphoma; 2004 Oct; 45(10):2063-70. PubMed ID: 15370251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation.
    Porrata LF; Gastineau DA; Padley D; Bundy K; Markovic SN
    Leuk Lymphoma; 2003 Jun; 44(6):997-1000. PubMed ID: 12854901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
    Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
    Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
    Kako S; Izutsu K; Kato K; Kim SW; Mori T; Fukuda T; Kobayashi N; Taji H; Hashimoto H; Kondo T; Sakamaki H; Morishima Y; Kato K; Suzuki R; Suzumiya J;
    Am J Hematol; 2015 Feb; 90(2):132-8. PubMed ID: 25382792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation.
    Eksioglu EA; Kielbasa J; Eisen S; Reddy V
    Cytotherapy; 2011 Aug; 13(7):888-96. PubMed ID: 21609205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early immune reconstitution after hematopoietic stem cell transplantation].
    Zhu MX; Wan WL; Li HS; Wang J; Wang YF; Hu K; Ke XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):515-22. PubMed ID: 27318917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas.
    Batorov EV; Shevela EY; Tikhonova MA; Batorova DS; Ushakova GY; Sizikova SA; Sergeevicheva VV; Gilevich AV; Kryuchkova IV; Ostanin AA; Chernykh ER
    Cell Immunol; 2015 Oct; 297(2):80-6. PubMed ID: 26227214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repopulation of circulating T, B and NK lymphocytes following bone marrow and blood stem cell transplantation.
    Parrado A; Casares S; Prieto J; Carmona M; Vaquero A; Rodríguez-Fernández JM
    Hematol Cell Ther; 1997 Dec; 39(6):301-6. PubMed ID: 9497889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.